14.05.2020
- German pharmaceuticals and life sciences group Merck has won US approval for its CRISPR-Cas9-assisted genome-editing patents and now is looking to license the technology to US...
27.04.2020
- German pharmaceuticals, chemicals and Life Science group Merck has acquired Konica Minolta’s entire OLED patent portfolio for display applications for an undisclosed sum. The...
23.04.2020
- German pharmaceuticals and chemicals producer Merck KGaA has announced plans to start up a second commercial manufacturing facility for viral and gene therapy products at its...
26.02.2020
- Together for Sustainability (TFS), a global, procurement-driven chemical industry initiative emphasizing sustainable supply chains, has further increased its impact by adding...
21.02.2020
- As part of its new strategy to concentrate on innovative medicines for the unmet medical needs of patients with difficult-to-treat diseases, Germany’s Merck KGaA has decided to...
04.02.2020
- German pharmaceuticals, chemicals and life sciences group Merck KGaA is investing €250 million over three years in a new facility at Corsier-sur-Vevey, Switzerland, which will be...
13.11.2019
- Germany’s Merck has signed a license agreement with Evotec, granting the Hamburg-based internationally active biotechnology group access to its CRISPR genome-editing technology...
30.10.2019
- German pharmaceuticals, chemicals and life science group Merck has launched a €13 million seed fund to support start-ups in China. At the opening of its Innovation Hub Shanghai...
